| Bioactivity | Alogliptin impurity 7-d3 is deuterium labeled (R)-2-((6-(3-((3-(2-cyanobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile[1]. |
| CAS | 2714473-43-3 |
| Formula | C31H27D3N8O4 |
| Molar Mass | 581.64 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. |
Alogliptin impurity 7-d3
CAS: 2714473-43-3 F: C31H27D3N8O4 W: 581.64
Alogliptin impurity 7-d3 is deuterium labeled (R)-2-((6-(3-((3-(2-cyanobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyri
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.